Aidsmap (NAM)
Today's post from International AIDS Conference
Contents:
"New drug – rilpivirine does well in trials
New drug – experimental integrase inhibitor shows promise
HIV and hepatitis C – bone problems more common
HIV and children – early treatment cost-effective
HIV and tuberculosis – rapid ART saves lives
Human rights central to HIV prevention for men who have sex with men
Extended-release nevirapine works well
Where now for AIDS activism?
Treatment literacy illustrated – and translated
More coverage of the conference"
0 comments:
Post a Comment